{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"62oFL3Qm9t\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/14064\/\">2006 \u5e74 3 \u6708 10 \u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/14064\/embed\/#?secret=62oFL3Qm9t\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for March 10, 2006&#8221; &#8212; Brakke Consulting Website\" data-secret=\"62oFL3Qm9t\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for March 10, 2006 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS: &nbsp; earnings news Bayer CEVA Embrex &nbsp; &nbsp; other news Alpharma Boehringer Ingelheim Vetmedica Clorox Henry Schein Intervet KMG Chemicals Lucky Litter Microgy NLS Animal Health Swift and Co. &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Bayer reported results for the year 2005.&nbsp; Animal Health group sales were EUR 856 million ($1,014 million), an increase of 9% compared to 2004. The increase was mainly the result of strong performance by Advantage product line in the US.&nbsp; Also contributing to growth were the launch of Advocate and Profender parasiticides in Europe and Canada. (company website)&nbsp;&nbsp; &nbsp; &gt; CEVA Sante Animale reported results for the full year 2005. The CEVA veterinary pharmaceutical group finished the 2005 financial year on consolidated turnover of EUR 271 million ($321 million), up 17.3% on 2004. On the same consolidation basis, turnover was up 7%. The Group achieved an exceptional performance in Europe with a special mention for the countries of Northern and Central Europe. Growth in Latin America and Asia also contributed to CEVA&rsquo;s excellent results over the financial year as a whole. (company press release) &nbsp; &gt; Embrex, Inc. announced financial results for the fullView Full Post;"}